Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Antibody, Antigen, And Assay Development Products

April 12, 2004 7:45 am | Articles | Comments

Over 350 products are featured in this catalog, with special sections outlining antibodies to bioterrorism agents, food and waterborne pathogens, and toxins.

TOPICS:

Mini Valves, Fittings, And Quick Disconnects

April 12, 2004 7:45 am | Articles | Comments

The 2004-2005 Catalog Beswick Engineering describes a line of miniature valves, fittings, cylinders, tubing, pressure regulators, orifice, quick disconnects, and other fluid power devices.

Peptides, Biochemicals

April 12, 2004 7:45 am | Articles | Comments

The 2004 Bachem catalog covers peptides, proteins, and related immunochemicals, enzyme inhibitors and substrates, amino acid derivatives, resins, and organic compounds.

Advertisement

Bioanalytical Sample Preparation Products Catalog

April 12, 2004 7:45 am | Articles | Comments

This company has released a catalog of bioanalytical sample preparation products for scientists isolating drug candidates from biological fluids in discovery support, pre-clinical, and clinical studies.

Cell Biology Products

April 12, 2004 7:45 am | Articles | Comments

The Active Motif 2004 catalog features a variety of products for transcription factor, cell

TOPICS:

Human Protein Microarrays Find Targets Faster 4/8/04

April 8, 2004 1:30 pm | Articles | Comments

by Elizabeth Tolchin A series of new human protein microarray, set to hit the market later this year, are already making a good impression on researchers at Yale who are looking for kinases involved in chronic myelogenous leukemia (CML).

Software Makes Short Work of High-Volume Genetic Variation Analysis 4/7/04

April 7, 2004 1:06 pm | Articles | Comments

by Elizabeth Tolchin Researchers looking for genes involved in complex neurological and psychiatric illnesses are using a new software tool for handling high-throughput genotyping assays.

TOPICS:

Combination Enhances Herceptin Antitumor Effect 4/6/04

April 7, 2004 7:35 am | Articles | Comments

by Elizabeth Tolchin A novel combination of a tumor suppressor with a growth factor inhibitor is yielding promising results for breast cancer.

TOPICS:
Advertisement

Immune-Response Gene Predicts Deadly Drug Side Effect 4/5/04

April 5, 2004 12:01 pm | Articles | Comments

by Elizabeth Tolchin In a pharmacogenomic study, researchers found a genetic marker related to immune response for Stevens-Johnson syndrome (SJS), a life-threatening skin condition brought about by an adverse reaction to certain medications.

TOPICS:

Peptides Fight the Fusion of SARS Virus 4/2/04

April 2, 2004 11:36 am | Articles | Comments

by Elizabeth Tolchin By using past experience from the study of fusion-inhibitory peptides in HIV, researchers found a similar inhibitory mechanism for severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV).

TOPICS:

Caviar on a Plate: Zebrafish Embryo Assay for Early Drug Screening 4/1/04

April 1, 2004 12:41 pm | Articles | Comments

by Elizabeth Tolchin A contract research organization was granted a patent this week that covers the use of zebrafish ( Danio rerio ) for drug screening using microliter plates.

TOPICS:

Antibody Technology Sprouts Start-Up in Texas Panhandle 3/31/04

March 31, 2004 11:57 am | Articles | Comments

by Elizabeth Tolchin By developing a novel antibody drug discovery technology, researchers from Texas Tech University, Amarillo, Texas, spawned a start-up firm, now six weeks young. Venture capital firm Emergent Technologies Inc., Austin, Texas, licensed the technology from the university and formed the start-up, Receptor Logic Ltd.

TOPICS:

Growth Factor Inhibitors Show Growth Potential 3/30/04

March 30, 2004 11:45 am | Articles | Comments

by Elizabeth Tolchin The FDA approved a new cancer treatment candidate by Genentech Inc., South San Francisco, called Avastin, this February. A recombinant humanized antibody to vascular endothelial growth factor (VEGF), the drug is designed to bind to and inhibit VEGF, a protein that plays a role in tumor angiogenesis.

TOPICS:

FDA Use of Biomarker Data Finds Likely Support 3/29/04

March 29, 2004 11:09 am | Articles | Comments

by Elizabeth Tolchin In support of the US Food and Drug Administration (FDA) initiative on the use of pharmacogenomic data in the drug submission process, Iconix Pharmaceuticals Inc. is releasing a set of its proprietary Drug Signature genomic biomarkers to the scientific community for research and validation.

TOPICS:

Drug Discovery Software Puts Library on Bench Chemists' Lap 3/26/04

March 26, 2004 11:58 am | Articles | Comments

by Elizabeth Tolchin A structure-guided drug discovery company is using software that allows their bench chemists to handle library design and enumeration. Optive Research Inc., recently deployed the software, called Benchware, for Structural GenomiX (SGX).

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading